Emcure Pharmaceuticals Q2 Results
- BSE: 544210
- NSE: EMCURE
- ISIN: INE168P01015
- Sector: -
BSE
1,317.55
3.95 (0.30%)
3.95 (0.30%)Volume3.73 K
Updated: Mon 25 Nov, 2024 | 15:29:04
NSE
1,312.05
-2.10 (-0.16%)
-2.10 (-0.16%)Volume1.01 L
Updated: Mon 25 Nov, 2024 | 15:31:30
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹2,001.98 Cr.(10.29%)
- Operating Profit₹283.98 Cr.(16.99%)
- Profit After Tax₹194.57 Cr.(35.04%)
- Operating Margin14.18%(-7.23%)
Note: Comparison is on YoY basis
Quarterly - Emcure Pharmaceuticals Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 24 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 2,001.98 | 1,815.14 | -% | 3,219.25 | -% |
| Selling/ General/ Admin Expenses Total | 355.59 | 350.40 | -% | 918.74 | -% |
| Depreciation/ Amortization | 96.90 | 93.59 | -% | 137.45 | -% |
| Other Operating Expenses Total | 476.85 | 445.32 | -% | 429.95 | -% |
| Total Operating Expense | 1,718.01 | 1,572.41 | -% | 2,734.64 | -% |
| Operating Income | 283.98 | 242.73 | -% | 484.61 | -% |
| Net Income Before Taxes | 273.41 | 207.41 | -% | 389.37 | -% |
| Net Income | 194.57 | 144.08 | -% | 269.56 | -% |
| Diluted Normalized EPS | 10.33 | 7.95 | -% | 14.40 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST